Arrowstreet Capital’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $154M | Sell |
|
|||||
|
2024
Q3 | $72.2M | Buy |
|
|||||
|
2024
Q2 | $94.3M | Buy |
|
|||||
|
2024
Q1 | $17.4M | Sell |
|
|||||
|
2023
Q4 | $41.8M | Buy |
|
|||||
|
2023
Q3 | $40.2M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $333K | Sell |
|
|||||
|
2022
Q3 | $13.6M | Sell |
|
|||||
|
2022
Q2 | $18.7M | Buy |
|
|||||
|
2022
Q1 | $19M | Buy |
|
|||||
|
2021
Q4 | $1.54M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $8.05M | Sell |
|
|||||
|
2020
Q3 | $30.6M | Sell |
|
|||||
|
2020
Q2 | $60.2M | Buy |
|
|||||
|
2020
Q1 | $23.9M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $7.27M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $37.3M | Buy |
|
|||||
|
2018
Q3 | $11.9M | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $11.6M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $33.4M | Sell |
|
|||||
|
2015
Q3 | $107M | Sell |
|
|||||
|
2015
Q2 | $114M | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $394M | Buy |
|
|||||
|
2014
Q3 | $111M | Buy |
|
|||||
|
2014
Q2 | $3.49M | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $10.8M | Buy |
|
|||||
|
2013
Q3 | $6.28M | Buy |
|